Oct 18 Cassiopea SpA :
* Announces completion of phase II proof of concept of its novel antibiotic for acne and decision to pursuefurther development
* Louise Dube, director of research and development is retiring at year end. Her responsibilities will be assumed by CSO Luigi Moro and Alessandro Mazzetti, CMO of Cosmo Pharmaceuticals. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.